CureSearch for Children’s Cancer has launched Requests for Applications (RFA) for high-impact osteosarcoma translational research, with a focus on moving quickly toward improvements in outcomes for patients.
Projects can be investigator-initiated, intervention-oriented studies or translational research to create new therapeutic options.
The total award amount is $1.5 million, which will be distributed in the amount of $500,000 per year, over a three-year period. We are better together and therefore, we’re very excited to partner with St. Baldrick’s Foundation, Battle Osteosarcoma, Children’s Cancer Research Fund, The Osteosarcoma Collaborative, and April and Michael Egge on this shared mission to cure pediatric osteosarcoma.
Please circulate this information to others who may be interested, and let us know if you have further questions.
Apply today at https://proposalcentral.com/. Letters of Intent are to be submitted by December 9, 2022, 5:00 PM ET through ProposalCentral. You can also review the full RFA in ProposalCentral for eligibility and application information. Click here for instructions on how to create a new ProposalCentral account